CLINICAL_TRIALS
research
· 2026-04-08
Clinical Trial Update: Performance and Safety of Afluxin® in Patients With Gastroesophageal Reflux Disease [NA]
Summary
An update on an ongoing clinical trial evaluating the performance and safety of Afluxin® in patients with gastroesophageal reflux disease. The study is currentl…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Devintec Sagl | Conditions: Gastroesophageal Reflux Disease (GERD) | NA | Status: RECRUITING